C. Marlowe

发表

Peptoids: a modular approach to drug discovery.

L Wang, Bartlett, F. Cohen, 1992, Proceedings of the National Academy of Sciences of the United States of America.

Modification of a receptor-binding surface of epidermal growth factor (EGF): analogs with enhanced receptor affinity at low pH or at neutrality.

G. Montelione, J. Blaney, S. Rosenberg, 1998, Protein engineering.

Phosphonamidate inhibitors of human neutrophil collagenase.

H. V. Van Wart, P. Bartlett, K. Mookhtiar, 1987, Biochemistry.

Antithrombotic and hemostatic capacity of factor Xa versus thrombin inhibitors in models of venous and arteriovenous thrombosis.

B. Zhu, C. Marlowe, S. Hollenbach, 2000, European journal of pharmacology.

EFFICIENT METHOD FOR REGIOSELECTIVE ISOPRENYLATION OF CYSTEINE THIOLS IN UNPROTECTED PEPTIDES

R. Kania, C. Marlowe, C. Yang, 1991 .

Evaluation of intrinsic binding energy from a hydrogen bonding group in an enzyme inhibitor.

P. Bartlett, C. Marlowe, 1987, Science.

Thermal rearrangements of propargylic trichloroacetimidates. Synthesis of (trichloroacetamido)-1,3-dienes and -1,2-dienes

L. Overman, C. Marlowe, L. Clizbe, 1981 .

The preparation of N-trichloroacetamido-1,2-dienes

L. Overman, C. Marlowe, L. Clizbe, 1979 .

Phosphorus-containing peptide analogs as peptidase inhibitors.

J. Hanson, P. Bartlett, C. Marlowe, 1987, Cold Spring Harbor symposia on quantitative biology.

An Analysis of the Enzyme-Inhibitor Binding Interactions for Phosphonic Acid Transition State Analogs of Thermolys in

P. Bartlett, C. Marlowe, 1987 .

Possible role for water dissociation in the slow binding of phosphorus-containing transition-state-analogue inhibitors of thermolysin.

P. Bartlett, C. Marlowe, P A Bartlett, 1987, Biochemistry.

Phosphonamidates as transition-state analogue inhibitors of thermolysin.

P. Bartlett, C. Marlowe, 1983, Biochemistry.

Peptide cyclization on TFA labile resin using the trimethylsilyl (TMSE) ester as an orthogonal protecting group

C. Marlowe, 1993 .

The Selective PI3K Inhibitor XL147 (SAR245408) Inhibits Tumor Growth and Survival and Potentiates the Activity of Chemotherapeutic Agents in Preclinical Tumor Models

K. Yamaguchi, D. J. Matthews, F. Yakes, 2015, Molecular Cancer Therapeutics.

Design, synthesis and structure-activity relationship of a series of arginine aldehyde factor Xa inhibitors. Part 1: structures based on the (D)-Arg-Gly-Arg tripeptide sequence.

C. Marlowe, C K Marlowe, R. Scarborough, 2000, Bioorganic & medicinal chemistry letters.

Design and synthesis of glycolic and mandelic acid derivatives as factor Xa inhibitors.

J. Woolfrey, B. Zhu, C. Marlowe, 2001, Bioorganic & medicinal chemistry letters.

Solid phase organic synthesis (SPOS): A novel route to diketopiperazines and diketomorpholines

Aaron C. Siegmund, C. Marlowe, Y. Pei, 1996, Molecular Diversity.

Hydroxamate based inhibitors of adenylyl cyclase. Part 1: the effect of acyclic linkers on P-site binding.

D. Cherbavaz, M. Bao, J. Tomlinson, 2003, Bioorganic & medicinal chemistry letters.

Free C-Terminal Resin-Bound Peptides: Reversal of Peptide Orientation via A Cyclization/Cleavage Protocol

R. Kania, R. Zuckermann, C. Marlowe, 1994 .

Activation of cannabinoid CB2 receptors by (−)-cannabichromene but not (+)-cannabichromene

P. Barr, M. Connor, C. Marlowe, 2023, bioRxiv.

Cannabichromene Racemization and Absolute Stereochemistry Based on a Cannabicyclol Analog.

M. Pirrung, P. Barr, C. Marlowe, 2021, Journal of Organic Chemistry.